| RS2146775487 |
TRAPPC2
|
Health Risk |
Likely pathogenic |
— |
| RS2146776296 |
TRAPPC2
|
Health Risk |
Likely pathogenic |
— |
| RS2146776508 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2146785767 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146785809 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146786648 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146786666 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146788855 |
NEDD4L
|
Health Risk |
Likely pathogenic |
— |
| RS2146792205 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2146794652 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2146796828 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146801880 |
CYBB
|
Health Risk |
Likely pathogenic |
— |
| RS2146801885 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146801935 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146801939 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146801959 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146803092 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146804063 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146804825 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2146805381 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146807050 |
ANOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146807429 |
NPHS1
|
Health Risk |
Likely pathogenic |
— |
| RS2146807976 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS2146808453 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2146810198 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS2146810272 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2146810847 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146811730 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146811786 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146811863 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146812210 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS2146812253 |
NPHS1
|
Health Risk |
Likely pathogenic |
— |
| RS2146812849 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813259 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813509 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813554 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813598 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813607 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS2146813611 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813622 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146813670 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813695 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813711 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS2146813723 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS2146813725 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146813743 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146813757 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2146813774 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146813797 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813832 |
KCNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2146813853 |
KCNB1
|
Health Risk |
Pathogenic |
— |
| RS2146813885 |
KCNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2146813951 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813954 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146813980 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS2146814335 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2146814454 |
SNTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS2146815883 |
KDM5C
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2146815940 |
KDM5C
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2146816256 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS2146816347 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS2146816353 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS2146817045 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146817067 |
CYBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS2146817094 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146817108 |
ANOS1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146817110 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146817170 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146817207 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146817260 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146817275 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146817773 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2146817932 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS2146818057 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146818103 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146818902 |
NPHS1
|
Health Risk |
Likely pathogenic |
— |
| RS2146819027 |
KDM5C
|
Health Risk |
Likely pathogenic |
— |
| RS2146819053 |
HPS4
|
Health Risk |
Likely pathogenic |
— |
| RS2146819139 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146819334 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146819513 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS2146819530 |
NPHS1
|
Health Risk |
Likely pathogenic |
— |
| RS2146819649 |
DMD
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Duchenne muscular dystrophy |
| RS2146819794 |
NPHS1
|
Health Risk |
Likely pathogenic |
— |
| RS2146819844 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS2146819931 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS2146820376 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2146820641 |
KDM5C
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2146821009 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS2146821097 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146821137 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS2146821175 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2146821257 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2146821316 |
KDM5C
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic X-linked intellectual disability Claes-Jensen type, Spastic paraplegia |
| RS2146821542 |
DMD
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2146821772 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2146821851 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS2146821938 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2146822012 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS2146822029 |
CYBB
|
Health Risk |
Pathogenic/Likely pathogenic |
Granulomatous disease, chronic |